SCHEMBL6422129

SCHEMBL6422129

C=CC[C@H](CNC)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.45
CYP2C19 P33261 1/20 0.44
SLC6A2 P23975 10/20 0.41
SLC6A4 P31645 10/20 0.41
SLC6A3 Q01959 8/20 0.41
HTR2A P28223 2/20 0.41
HRH1 P35367 2/20 0.41
CYP2D6 P10635 5/20 0.41
KCNH2 Q12809 4/20 0.41
CYP3A4 P08684 4/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8031389 1.00 TAAR1 (0.48) TAAR1SMN1; SMN2CYP2C19SLC6A2SLC6A4
SCHEMBL6421394 1.00 TAAR1 (0.48) TAAR1SMN1; SMN2CYP2C19SLC6A2SLC6A4
SCHEMBL22097765 0.84 TDP1 (0.34) TAAR1SMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL493770 0.82 SLC6A2 (0.35) TAAR1SMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL22728188 0.82 ATM (0.44) TAAR1SMN1; SMN2CYP2C19SLC6A2SLC6A4
SCHEMBL4259328 0.82 SLC6A2 (0.35) TAAR1SMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL9003499 0.82 CYP2C19 (0.55) TAAR1SMN1; SMN2CYP2C19HTR2ACYP2D6
SCHEMBL8329957 0.80 SLC6A4 (0.44) TAAR1SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL8045114 0.80 SLC6A4 (0.44) TAAR1SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL11775077 0.79 CYP2C19 (0.46) SMN1; SMN2CYP2C19CYP2D6ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077942-B1 CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS AVENTIS PHARMA INC (US) 2005-01-12 EP disclosed
US-6316445-B1 TACHYKININ RECEPTOR ANTAGONISTS AVENTIS PHARMACEUTICALS INC. 2001-11-13 US disclosed
EP-1077942-A1 CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS Aventis Pharmaceuticals Inc. (US) 2001-02-28 EP disclosed
US-6136827-A PIPERIDINE COMPOUNDS AS DRUGS MERCK & CO., INC. (US) 2000-10-24 US disclosed
EP-1003514-A1 CYCLIC AMINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2000-05-31 EP disclosed
WO-1999059972-A1 CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 1999-11-25 WO disclosed
US-5932571-A Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases HOECHST MARION ROUSSEL, INC. (US) 1999-08-03 US disclosed
WO-1999004794-A1 CYCLIC AMINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1999-02-04 WO disclosed